Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Kawashima

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Hematology|August 7, 2024
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trialKazuya Shimoda, Norio Komatsu, Itaru Matsumura, et al.
Journal of Surgical Oncology|November 22, 2024
Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function AnalysisJun Kawashima, Miho Akabane, Yutaka Endo, et al.
Journal of Surgical Oncology|October 14, 2024
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Yuki Homma, et al.
The Lancet. Haematology|December 25, 2017
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trialClaire N Harrison, Alessandro M Vannucchi, Uwe Platzbecker, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 26, 2025
Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profilesMiho Akabane, Jun Kawashima, Selamawit Woldesenbetm, et al.
Hepatobiliary Surgery and Nutrition|February 10, 2025
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approachJun Kawashima, Yutaka Endo, Zayed Rashid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2024
Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and stationJun Kawashima, Abdullah Altaf, Yutaka Endo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2025
Preoperative diagnostic failure in gallbladder cancer: Influence of tumor location and size on imaging precisionMiho Akabane, Jun Kawashima, Abdullah Altaf, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 19, 2025
Recurrence patterns and prediction of survival after recurrence for gallbladder cancerGiovanni Catalano, Laura Alaimo, Odysseas P Chatzipanagiotou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2025
Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden scoreOdysseas P Chatzipanagiotou, Jun Kawashima, Andrea Baldo, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Hematology|August 7, 2024
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trialKazuya Shimoda, Norio Komatsu, Itaru Matsumura, et al.
Journal of Surgical Oncology|November 22, 2024
Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function AnalysisJun Kawashima, Miho Akabane, Yutaka Endo, et al.
Journal of Surgical Oncology|October 14, 2024
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Yuki Homma, et al.
The Lancet. Haematology|December 25, 2017
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trialClaire N Harrison, Alessandro M Vannucchi, Uwe Platzbecker, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 26, 2025
Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profilesMiho Akabane, Jun Kawashima, Selamawit Woldesenbetm, et al.
Hepatobiliary Surgery and Nutrition|February 10, 2025
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approachJun Kawashima, Yutaka Endo, Zayed Rashid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2024
Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and stationJun Kawashima, Abdullah Altaf, Yutaka Endo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2025
Preoperative diagnostic failure in gallbladder cancer: Influence of tumor location and size on imaging precisionMiho Akabane, Jun Kawashima, Abdullah Altaf, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 19, 2025
Recurrence patterns and prediction of survival after recurrence for gallbladder cancerGiovanni Catalano, Laura Alaimo, Odysseas P Chatzipanagiotou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2025
Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden scoreOdysseas P Chatzipanagiotou, Jun Kawashima, Andrea Baldo, et al.
Pageof 11